Back to search

Article

SNPD-siKRAS: siRNA specifically inhibits KRAS with a single-nucleotide mutation

2025-09-20

Abstract excerpt

<h4>SUMMARY</h4> Kirsten Rat Sarcoma Viral Oncogene Homolog ( KRAS ) is the most frequently mutated gene associated with pancreatic cancer. However, targeting mutated KRAS without affecting the wild-type KRAS expression by conventional chemotherapy is challenging, because KRAS protein is considered to be undruggable due to the lack of surface structures for drug binding. Here, we developed a single-nucleotide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8c853b5-1c17-57be-bf50-37787859c267
DOI
10.1101/2025.09.18.677211
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SNPD-siKRAS: siRNA specifically inhibits KRAS with a single-nucleotide mutationDOI 10.1101/2025.09.18.677211
Select a neighboring publication to make it the new centre.